Acquisition Opportunity Cascade Specialty Pharmacy was acquired by Revelation Pharma in January 2025, which may open cross-sell opportunities with Revelation’s national network of 503A and 503B pharmacies and potential integration or up-sell of CSP’s personalized compounding capabilities to a broader customer base.

Personalized Care Strength Leverage CSP’s focus on tailored medications and physician partnerships to position high-value, custom formulations in urology, hormone replacement, women’s health, dermatology, and veterinary medicine as premium offerings within partner networks and payer channels.

Mid-market Growth With 11–50 employees and annual revenue in the $10–25M range, CSP represents a mid-market specialty pharmacy with room to scale through expanded commercial programs, clinical education services, and enhanced patient satisfaction initiatives to attract larger health systems.

Tech Stack Advantage CSP’s technology footprint including order management, site optimization, and validation tooling can be highlighted to prospective partners for efficiency gains, faster time-to-patient, and improved accuracy claim resolutions in a sales outreach strategy.

Diversified Specialties CSP’s portfolio spans urology, sinus health, hormone therapy, women’s health, dermatology, and veterinary medicine, offering multiple entry points for strategic collaborations, co-marketing with physicians, and bundled services across specialty channels.